Qingdao Baheal Medical INC. (301015 SHE) stock market data APIs

Qingdao Baheal Medical INC. engages in the research and development, production, and sale of pharmaceutical products. The company offers bone health drugs under the D-Cal brand name; digestive drugs under the Mite brand name ; liver disease drugs under the Fuzhenghuayu brand name ; and urological drugs under the Betanli, Harle, and Wei Xi Kang brand names. It also provides ophthalmic drugs under the HYCOSAN brand name ; tumor and other severe drugs under the Human Albumin and Xospata brands; anti-aging and cosmeceuticals under the Quanis, Excellula, TRANSINO, Qingchunbao; diabetes drugs under the Naida, Feburic, and Naite brand; respiratory and anti-infective under the Klacid brand; medical nutrition under the Nutrasumma brand name. The company was founded in 2005 and is based in Qingdao, China.